Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, 52-week, Double-blind, Parallelgroup, Active Controlled Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
Brief Summary: The purpose of the trial was to evaluate the efficacy and safety of two different doses of QVM149 (QVM149 150/50/80 μg and QVM149 150/50/160 μg via Concept1) over two respective QMF149 doses (QMF149 150/160 μg and QMF149 150/320) μg via Concept1 in poorly controlled asthmatics as determined by pulmonary function testing and effects on asthma control.


Options:
A: Arm Label: Fp MDPI 100 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol HFA | Arm Label: FLOVENT HFA 110 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT HFA, Drug: albuterol/salbutamol HFA | Arm Label: Fp MDPI 200 mcg; Type: EXPERIMENTAL; Interventions: Drug: Fp MDPI, Drug: albuterol/salbutamol HFA | Arm Label: FLOVENT HFA 220 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT HFA, Drug: albuterol/salbutamol HFA | Arm Label: FS MDPI 100/12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol HFA | Arm Label: ADVAIR DISKUS 250/50 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: ADVAIR DISKUS, Drug: albuterol/salbutamol HFA | Arm Label: FS MDPI 200/12.5 mcg; Type: EXPERIMENTAL; Interventions: Drug: FS MDPI, Drug: albuterol/salbutamol HFA | Arm Label: ADVAIR DISKUS 500/50 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: ADVAIR DISKUS, Drug: albuterol/salbutamol HFA | Intervention Type: DRUG; Name: Fp MDPI; Assigned to Arm(s): Fp MDPI 100 mcg, Fp MDPI 200 mcg | Intervention Type: DRUG; Name: FS MDPI; Assigned to Arm(s): FS MDPI 100/12.5 mcg, FS MDPI 200/12.5 mcg | Intervention Type: DRUG; Name: FLOVENT HFA; Assigned to Arm(s): FLOVENT HFA 110 mcg, FLOVENT HFA 220 mcg | Intervention Type: DRUG; Name: ADVAIR DISKUS; Assigned to Arm(s): ADVAIR DISKUS 250/50 mcg, ADVAIR DISKUS 500/50 mcg | Intervention Type: DRUG; Name: albuterol/salbutamol HFA; Assigned to Arm(s): ADVAIR DISKUS 250/50 mcg, ADVAIR DISKUS 500/50 mcg, FLOVENT HFA 110 mcg, FLOVENT HFA 220 mcg, FS MDPI 100/12.5 mcg, FS MDPI 200/12.5 mcg, Fp MDPI 100 mcg, Fp MDPI 200 mcg
B: Arm Label: QVM149 150/50/160 µg o.d.; Type: EXPERIMENTAL; Interventions: Drug: QVM149 150/50/160 | Arm Label: QVM149 150/50/80 µg o.d.; Type: EXPERIMENTAL; Interventions: Drug: QVM149 150/50/80 | Arm Label: QMF149 150/320 µg o.d.; Type: ACTIVE_COMPARATOR; Interventions: Drug: QMF149 150/320 | Arm Label: QMF149 150/160 µg o.d.; Type: ACTIVE_COMPARATOR; Interventions: Drug: QMF149 150/160 | Arm Label: Salmeterol/fluticasone 50/500 μg b.i.d.; Type: ACTIVE_COMPARATOR; Interventions: Drug: salmeterol/fluticasone | Intervention Type: DRUG; Name: QVM149 150/50/160; Assigned to Arm(s): QVM149 150/50/160 µg o.d. | Intervention Type: DRUG; Name: QVM149 150/50/80; Assigned to Arm(s): QVM149 150/50/80 µg o.d. | Intervention Type: DRUG; Name: QMF149 150/320; Assigned to Arm(s): QMF149 150/320 µg o.d. | Intervention Type: DRUG; Name: QMF149 150/160; Assigned to Arm(s): QMF149 150/160 µg o.d. | Intervention Type: DRUG; Name: salmeterol/fluticasone; Assigned to Arm(s): Salmeterol/fluticasone 50/500 μg b.i.d.
C: Arm Label: Crossover sequence 1; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 2; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 3; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 4; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 100 mcg, Drug: Flovent Diskus® 250 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 5; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 6; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 7; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Arm Label: Crossover sequence 8; Type: EXPERIMENTAL; Interventions: Drug: Flovent Diskus® 250 mcg, Drug: Flovent Diskus® 500 mcg, Drug: Advair Diskus® 100/50 mcg, Drug: Advair Diskus® 250/50 mcg | Intervention Type: DRUG; Name: Flovent Diskus® 100 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4 | Intervention Type: DRUG; Name: Flovent Diskus® 250 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Flovent Diskus® 500 mcg; Assigned to Arm(s): Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Advair Diskus® 100/50 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8 | Intervention Type: DRUG; Name: Advair Diskus® 250/50 mcg; Assigned to Arm(s): Crossover sequence 1, Crossover sequence 2, Crossover sequence 3, Crossover sequence 4, Crossover sequence 5, Crossover sequence 6, Crossover sequence 7, Crossover sequence 8
D: Arm Label: Fluticasone furoate/GW642444; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/GW642444 | Arm Label: Fluticasone propionate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone propionate | Intervention Type: DRUG; Name: Fluticasone Furoate/GW642444; Assigned to Arm(s): Fluticasone furoate/GW642444 | Intervention Type: DRUG; Name: Fluticasone propionate; Assigned to Arm(s): Fluticasone propionate

Answer: B